← Back to Search

Support Groups for Bronchiectasis (BronchConnect Trial)

N/A

Recruiting

Led By Shoshana Zha, MD/PhD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Solid organ transplant recipient

Age < 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3-months, 6-months, 12-months

Awards & highlights

No Placebo-Only Group

Summary

This trial will assess if support groups improve quality of life for those with NCFBE, a chronic lung disease with no targeted therapy. It will measure quality of life, anxiety, and exacerbation rates.

Who is the study for?

This trial is for adults with non-cystic fibrosis bronchiectasis confirmed by a CT chest scan, where it's the main lung issue. Participants must be able to give informed consent and speak English well enough to have full conversations.

What is being tested?

The study examines how joining a virtual support group affects life quality and anxiety in people with NCFBE. It measures changes through questionnaires and checks if their condition gets worse less often.

What are the potential side effects?

Since this trial involves participation in a support group rather than medication, there are no direct medical side effects. However, discussing health issues could potentially cause emotional discomfort.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have received an organ transplant.

Select...

I am under 18 years old.

Select...

I have cystic fibrosis.

Select...

I have lung scarring with airway widening.

Select...

I cannot fully converse in English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3-months, 6-months, 12-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3-months, 6-months, 12-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3-months, 6-months, 12-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Anxiety

Health-related quality of life

Secondary study objectives

Exacerbation Rate

Participation

Rate of post-group survey

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Support GroupExperimental Treatment1 Intervention

Non-randomized pre-post trial, in which each participant will serve as their own control. Participants will be recruited from a bronchiectasis specialty clinic.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Support Group

2016

N/A

~640

0 / 5Eligibility criteria met